Treatment of intracranial inflammatory myofibroblastic tumor with PD-L1 inhibitor and novel oncolytic adenovirus Ad-TD-nsIL12: a case report and literature review

Overview of attention for article published in Frontiers in immunology, July 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 4 X users

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 34,787 followers.

RT @FrontImmunol: New Research: Treatment of intracranial inflammatory myofibroblastic tumor with PD-L1 inhibitor and novel oncolytic adeno…

26 Jul 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Treatment of intracranial inflammatory myofibroblastic tumor with PD-L1 inhibitor and novel oncolytic adeno…

26 Jul 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Treatment of intracranial inflammatory myofibroblastic tumor with PD-L1 inhibitor and novel oncolytic adeno…

26 Jul 2024

Reply Repost Favourite

New Research: Treatment of intracranial inflammatory myofibroblastic tumor with PD-L1 inhibitor and novel oncolytic adenovirus Ad-TD-nsIL12: a case report and literature review https://t.co/seWacNxTC8 #FrontiersIn #Immunology

26 Jul 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.